Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Oxygent research agreement restructured

May 18, 1998

Clinical efficacy and safety of sildenafil in men with ED

May 15, 1998

FDA advisory committee denies recommendation for Ergoset

May 15, 1998

PolyHeme to undergo European phase III trials

May 15, 1998

Abbott introduces new drug for hyperparathyroidism in U.S.

May 15, 1998

Anergen receives SBIR grant for diabetes treatment development

May 15, 1998

Senetek's ED treatment shows 83% response rate

May 15, 1998

Alprox-TD efficacy established in Argentinian clinical trial

May 15, 1998

Connetics and Genentech expand Actimmune collaboration

May 14, 1998

FDA issues approvable letter for Roche's novel antiobesity Rx

May 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...